Prescription Drugs
Introducing —GC Wellbeing’s Safe Medicine.
Medicine/Medical Device > Other inj.
GCCARTIN inj.
- Efficacy CategoryCarnitine deficiency, myocardial metabolic disorder
- Active Ingredient(s)L-Carnitine
- Medicinal Content0.2g/1ml
- Insurance codeNot covered
| Characteristics | Brown ampoule injection that contains colorless to pale-yellow liquid. |
|---|---|
| Full Ingredient | Active ingredient in 1mL: 0.2g of L-carnitine |
| Efficacy/Effect |
1) Primary and secondary carnitine deficiency 2) Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction 3) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis |
| Usage/Dosage |
1) Primary and secondary carnitine deficiency Myocardial metabolic disorders due to ischemic heart disease: angina pectoris, acute myocardial infarction Adults: Intramuscular injection or IV drip of 2~3g L-carnitine per day, divided into 2 or 3 doses. Increase or decrease the administered amount according to age and symptoms. 2) Treatment of carnitine deficiency in end-stage renal disease patients undergoing hemodialysis Initially, 10-20mg/kg is administered intravenously over a 2?3-minute period at the end of each hemodialysis. However, the dosage can be adjusted in accordance with the plasma L-carnitine level before hemodialysis. |
| Storage | Store in an opaque sealed container at room temperature (1~30℃) |
| Packaging Unit | 5ml * 25amps Ampoule injection |